Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.24.2.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash Flows from Operating Activities    
Net Loss $ (1,057,963) $ (8,442,247)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation
Amortization of stock options and restricted stock units 258,370 1,108,731
Depreciation and amortization 47,557 50,322
Change in fair value of derivative liabilities (58) (67,740)
Gain loss on settlement of liabilities (156,928)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 1,236,580 1,064,604
Accounts payable 654,156 (1,029,636)
Accounts payable - related parties (679,407) 53,257
Accrued expenses (716,069) 186,447
Accrued expenses – related parties 107,515 89,529
Total adjustments 751,716 1,455,514
Net Cash Used In Operating Activities (306,247) (6,986,733)
Cash Flows from Financing Activities    
Proceeds from exercise of pre-funded warrants from the Amendment to August 2023 Offering 489
Proceeds from sale of April 2023 Offering stock and warrants 2,999,882
Proceeds from exercise of April 2023 Offering pre-funded warrants 117
Payment of offering costs in connection with April 2023 Offering stock and warrants (279,994)
Repayment of loans payable (529,791) (727,542)
Net cash provided by (used in) financing activities (529,302) 1,992,463
Effect of Exchange Rate Changes on Cash 6,038 32,766
Net Decrease In Cash (829,511) (4,961,504)
Cash – Beginning of Period 1,975,799 6,970,110
Cash – End of Period 1,146,288 2,008,606
Supplemental Disclosures of Cash Flow Information:    
Cash paid during the period for income taxes
Cash paid during the period for interest expense 12,078 14,518
Non cash investing and financing activities    
Common stock issued for settlement of liabilities $ 523,251